Services: Regulatory

Regulatory Strategy

Cato Research has special expertise in devising regulatory and product development strategies that can increase the likelihood of regulatory approval of drugs, biologics, and medical devices. We work closely with sponsors to devise strategies that most effectively meet the developmental and business objectives for the product. Our strategies define the regulatory, clinical, nonclinical, and manufacturing steps essential for the successful development of the product.

Regulatory Interactions

Our senior staff members have many years of experience interacting with the FDA, the HPB, and other international regulatory agencies. Cato Research's detailed knowledge of the intricacies of these agencies and the reputation Cato Research has established over the years help to promote and coordinate constructive formal and informal regulatory meetings for sponsors. Cato Research is particularly skilled producing comprehensive pre-meeting submission packages and in moderating agency meetings to extract maximal guidance and advice.